212 related articles for article (PubMed ID: 32546843)
21. G84E mutation in HOXB13 is firmly associated with prostate cancer risk: a meta-analysis.
Huang H; Cai B
Tumour Biol; 2014 Feb; 35(2):1177-82. PubMed ID: 24026887
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness.
Storebjerg TM; Høyer S; Kirkegaard P; Bro F; ; Ørntoft TF; Borre M; Sørensen KD
BJU Int; 2016 Oct; 118(4):646-53. PubMed ID: 26779768
[TBL] [Abstract][Full Text] [Related]
23. The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland.
Kluźniak W; Wokołorczyk D; Kashyap A; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dębniak T; Gołąb A; Gliniewicz B; Sikorski A; Switała J; Borkowski T; Borkowski A; Antczak A; Wojnar L; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Sikorska-Radek P; Matych J; Wilkosz J; Różański W; Kiś J; Bar K; Bryniarski P; Paradysz A; Jersak K; Niemirowicz J; Słupski P; Jarzemski P; Skrzypczyk M; Dobruch J; Domagała P; Akbari MR; Lubiński J; Narod SA; Cybulski C;
Prostate; 2013 Apr; 73(5):542-8. PubMed ID: 23334858
[TBL] [Abstract][Full Text] [Related]
24. The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies.
Beebe-Dimmer JL; Hathcock M; Yee C; Okoth LA; Ewing CM; Isaacs WB; Cooney KA; Thibodeau SN
Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1366-72. PubMed ID: 26108461
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy.
Beebe-Dimmer JL; Isaacs WB; Zuhlke KA; Yee C; Walsh PC; Isaacs SD; Johnson AM; Ewing CE; Humphreys EB; Chowdhury WH; Montie JE; Cooney KA
BJU Int; 2014 May; 113(5):830-5. PubMed ID: 24148311
[TBL] [Abstract][Full Text] [Related]
26. Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy.
Schroeck FR; Zuhlke KA; Siddiqui J; Siddiqui R; Cooney KA; Wei JT
J Urol; 2013 Mar; 189(3):849-53. PubMed ID: 23036981
[TBL] [Abstract][Full Text] [Related]
27. HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer.
Johng D; Torga G; Ewing CM; Jin K; Norris JD; McDonnell DP; Isaacs WB
Prostate; 2019 Mar; 79(4):414-424. PubMed ID: 30560549
[TBL] [Abstract][Full Text] [Related]
28. Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in polish population.
Złowocka-Perłowska E; Tołoczko-Grabarek A; Lubiński J
Hered Cancer Clin Pract; 2022 Jan; 20(1):1. PubMed ID: 34983599
[TBL] [Abstract][Full Text] [Related]
29. Impact of the G84E variant on HOXB13 gene and protein expression in formalin-fixed, paraffin-embedded prostate tumours.
FitzGerald LM; Raspin K; Marthick JR; Field MA; Malley RC; Thomson RJ; Blackburn NB; Banks A; Charlesworth JC; Donovan S; Dickinson JL
Sci Rep; 2017 Dec; 7(1):17778. PubMed ID: 29259341
[TBL] [Abstract][Full Text] [Related]
30. The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: results from the REDUCE trial.
Chen Z; Greenwood C; Isaacs WB; Foulkes WD; Sun J; Zheng SL; Condreay LD; Xu J
Carcinogenesis; 2013 Jun; 34(6):1260-4. PubMed ID: 23393222
[TBL] [Abstract][Full Text] [Related]
31. Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank.
Wei J; Shi Z; Na R; Wang CH; Resurreccion WK; Zheng SL; Hulick PJ; Cooney KA; Helfand BT; Isaacs WB; Xu J
Br J Cancer; 2020 Oct; 123(9):1356-1359. PubMed ID: 32830201
[TBL] [Abstract][Full Text] [Related]
32. Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort.
Hoffmann TJ; Sakoda LC; Shen L; Jorgenson E; Habel LA; Liu J; Kvale MN; Asgari MM; Banda Y; Corley D; Kushi LH; Quesenberry CP; Schaefer C; Van Den Eeden SK; Risch N; Witte JS
PLoS Genet; 2015 Jan; 11(1):e1004930. PubMed ID: 25629170
[TBL] [Abstract][Full Text] [Related]
33. Germline mutations in HOXB13 and prostate-cancer risk.
Ewing CM; Ray AM; Lange EM; Zuhlke KA; Robbins CM; Tembe WD; Wiley KE; Isaacs SD; Johng D; Wang Y; Bizon C; Yan G; Gielzak M; Partin AW; Shanmugam V; Izatt T; Sinari S; Craig DW; Zheng SL; Walsh PC; Montie JE; Xu J; Carpten JD; Isaacs WB; Cooney KA
N Engl J Med; 2012 Jan; 366(2):141-9. PubMed ID: 22236224
[TBL] [Abstract][Full Text] [Related]
34. HOXB13 mutations in a population-based, case-control study of prostate cancer.
Stott-Miller M; Karyadi DM; Smith T; Kwon EM; Kolb S; Stanford JL; Ostrander EA
Prostate; 2013 May; 73(6):634-41. PubMed ID: 23129385
[TBL] [Abstract][Full Text] [Related]
35. Germline HOXB13 p.Gly84Glu mutation and cancer susceptibility: a pooled analysis of 25 epidemiological studies with 145,257 participates.
Cai Q; Wang X; Li X; Gong R; Guo X; Tang Y; Yang K; Niu Y; Zhao Y
Oncotarget; 2015 Dec; 6(39):42312-21. PubMed ID: 26517352
[TBL] [Abstract][Full Text] [Related]
36. Germline HOXB13 p.Gly84Glu mutation and risk of colorectal cancer.
Akbari MR; Anderson LN; Buchanan DD; Clendenning M; Jenkins MA; Win AK; Hopper JL; Giles GG; Nam R; Narod S; Gallinger S; Cleary SP
Cancer Epidemiol; 2013 Aug; 37(4):424-7. PubMed ID: 23541221
[TBL] [Abstract][Full Text] [Related]
37. HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease.
Habel LA; Sakoda LC; Achacoso N; Ma XJ; Erlander MG; Sgroi DC; Fehrenbacher L; Greenberg D; Quesenberry CP
Breast Cancer Res; 2013 Mar; 15(2):R24. PubMed ID: 23497539
[TBL] [Abstract][Full Text] [Related]
38. Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance.
Goetz MP; Suman VJ; Couch FJ; Ames MM; Rae JM; Erlander MG; Ma XJ; Sgroi DC; Reynolds CA; Lingle WL; Weinshilboum RM; Flockhart DA; Desta Z; Perez EA; Ingle JN
Clin Cancer Res; 2008 Sep; 14(18):5864-8. PubMed ID: 18794098
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of the HOXB13 G84E mutation among unaffected men with a family history of prostate cancer.
Handorf E; Crumpler N; Gross L; Giri VN
J Genet Couns; 2014 Jun; 23(3):371-6. PubMed ID: 24310616
[TBL] [Abstract][Full Text] [Related]
40. HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study.
Jansen MP; Sieuwerts AM; Look MP; Ritstier K; Meijer-van Gelder ME; van Staveren IL; Klijn JG; Foekens JA; Berns EM
J Clin Oncol; 2007 Feb; 25(6):662-8. PubMed ID: 17308270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]